Pennsylvania providers should schedule follow-up assessments every 48 weeks during titration to monitor gastrointestinal tolerance, weight, blood pressure, and metabolic markers
Effects of GLP-1 receptor agonists on biological behavior of colorectal cancer cells by regulating PI3k/Akt/mTOR signaling pathway
Ginger has been shown to potentially accelerate muscular contractions of the stomach leading to improved gastric emptying through an effect on cholinergic and serotonergic receptors [10]

To use the Medicare GLP-1 Bridge benefit, patients generally need to meet all of the following: Be enrolled in Medicare Part D (a standalone prescription drug plan or Medicare Advantage plan with prescription drug coverage) Be at least 18 years old AND meet one of three BMI-based eligibility tiers (more restrictive than the general FDA label): Tier 1: BMI of 35 or higher (no additional conditions required), or Tier 2: BMI of 30 or higher WITH heart failure with preserved ejection fraction, OR uncontrolled hypertension (systolic blood pressure above 140 mm Hg or diastolic above 90 mm Hg despite treatment with two antihypertensive medications), OR chronic kidney disease stage 3a or above, or Tier 3: BMI of 27 or higher WITH prediabetes (per American Diabetes Association guidelines), previous myocardial infarction, previous stroke, or symptomatic peripheral artery disease Be using the medication in combination with current and ongoing lifestyle modification including structured nutrition and physical activity Have a prescription from a qualified prescriber (any licensed clinician with prescribing authority can prescribe

This exemption disappears if the drug receives a second approval for a different rare disease or for a common indication
Why Novo Nordisk is charging Americans substantially higher prices for these drugs than the people in other countries